Revance Therapeutics Market Cap

JINS HOLDINGS has a market cap or net worth of 183.47 billion as of August 6, 2025. Its market cap has increased by 81.33% in one year.

Market Cap

183.47B

Enterprise Value

178.94B

Revenue

93.65B

Ranking

n/a

PE Ratio

23.84

Stock Price

$7,850.00

Market Cap Chart

Since November 28, 2006, JINS HOLDINGS's market cap has increased from 14.28B to 183.47B, an increase of 1,184.34%. That is a compound annual growth rate of 14.63%.

Market Cap History

Date	Market Cap	% Change
Aug 6, 2025	183.47B	22.06%
Dec 30, 2024	150.31B	37.02%
Dec 29, 2023	109.70B	1.95%
Dec 30, 2022	107.60B	-34.24%
Dec 30, 2021	163.61B	3.39%
Dec 30, 2020	158.25B	-10.57%
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 30, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Chugai Pharmaceutical	12.02T
Daiichi Sankyo Company	6,600.46B
Takeda Pharmaceutical Company	6,590.05B
HOYA Corporation	6,191.93B
Otsuka Holdings	3,913.98B
Terumo	3,753.27B
Astellas Pharma	2,786.62B
Shionogi &	2,166.95B

Market Cap Rankings